FDA Approves First Therapy to Reduce Pancreatitis Risk
-
By
-
Kathryn Wighton
-
June 24, 2026
-
2 min
By
Kathryn Wighton
June 24, 2026
A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.
October 26, 2026
Trial evidence translated into wider clinical use as postpartum infection rates declined in US practice.
September 30, 2026
The federal settlement resolves allegations of unlawful controlled substance prescribing and absent patient records and restricts future DEA registration for certain controlled substances.
October 1, 2026